Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms, Germ Cell and Embryonal × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 6 Prostatic Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Myeloid, Acute 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Ovarian Neoplasms 3 Lung Neoplasms 3 Thrombosis 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Recurrence 2 Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Multiple Myeloma 2 Disease 2 Carcinoma, Transitional Cell 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Cancer, Papillary 1 Thrombophilia 1 Thrombocytopenia 1 Thoracic Neoplasms 1 Skin Neoplasms 1 Pituitary Neoplasms 1 Pediatric Solid Tumor, Unspecified, Protocol Specific 1 Papillomavirus Infections 1

Interventions

Cisplatin 4 Etoposide 3 Carboplatin 3 etoposide phosphate 2 Paclitaxel 2 Bleomycin 2 pralsetinib 1 pembrolizumab 1 pegfilgrastim 1 Standard of Care 1 Specimen Handling 1 Respiratory Physiological Phenomena 1 Practice Guidelines as Topic 1 Platinum 1 Pemetrexed 1 Magnetic Resonance Spectroscopy 1 Injections 1 Ifosfamide 1 Granulocyte Colony-Stimulating Factor 1 Gemcitabine 1 Filgrastim 1 Biopsy 1 Aprepitant 1 130-nm albumin-bound paclitaxel 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02582697 2025-06-15

P3BEP

University of Sydney

Phase 3 Recruiting

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡